![]()  | |
![]()  | |
| Names | |
|---|---|
| Preferred IUPAC name
 N-Methylpyridine-3-carboxamide  | |
| Other names
 N-Methylnicotinamide; N-Methylniacinamide  | |
| Identifiers | |
3D model (JSmol)  | 
|
| Abbreviations | NAN | 
| ChEBI | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.003.679 | 
| EC Number | 
  | 
| MeSH | C008472 | 
PubChem CID  | 
|
| UNII | |
CompTox Dashboard (EPA)  | 
|
  | |
  | |
| Properties | |
| C7H8N2O | |
| Molar mass | 136.154 g·mol−1 | 
| Pharmacology | |
| A05AB01 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
Nicotinyl methylamide is an experimental drug with no approved indication.[1] It is also a metabolite of nicotinamide (vitamin B3) and is found in urine.[2]
See also
References
- ↑ "N-methylnicotinamide". DrugBank.
 - ↑ "Nicotinyl methylamide". Inxight Drugs. National Center for Advancing Translational Sciences.
 
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

